Although ACE2-inhibiting activity after primary infection and vaccination was similar, infection-induced ACE2 inhibition depended mostly on mucosal IgA, while post-vaccination inhibition was mainly attributable to mucosal IgG. The gene discussed is CD79A; the disease is infection.